Electra Therapeutics
South San Francisco, US · Delaware corporation · 3 known investors
Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.
BiotechHealthtechMedical Devices
Founders & leadership
Q(
Quehuong (Kathy) Dong, Pharm.D.Executive
Board
BS
Beth Seidenberg, M.D.Board director
TG
Thomas Geninatti, Ph.D.Board director
CG
Carl Gordon, Ph.D.Board director
MF
Matthew FustBoard director
NS
Nancy Stagliano, Ph.D.Board director
Investors · 3
Reported raises · per SEC filings
Form D private placements$134.2M disclosed across 1 round · 2025
▶$134.2MraisedOct 2025 · 19 investors · BiotechnologyRule 506(b)
▶$134.2MraisedOct 2025 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Beth Seidenberg, M.D.Director
- Thomas Geninatti, Ph.D.Director
- Matthew FustDirector
- Carl Gordon, Ph.D.Director
- Nancy Stagliano, Ph.D.Director
- Quehuong (Kathy) Dong, Pharm.D.Executive Officer, Director
- Offering amount
- $184.1M
- Amount sold
- $134.2M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapElectra18 shared keywordsElectra develops a chemistry-based iron production process powered by clean energy to produce iron at scale without environmental damage. The company serves industrial iron and steel manufacturers.
AltaThera Pharmaceuticals18 shared keywordsAltaThera Pharmaceuticals develops hospital-use intravenous drug therapies for treating cardiovascular conditions such as atrial fibrillation, atrial flutter, and ventricular arrhythmias in adult and pediatric patients. Its intravenous approach to antiarrhythmic initiation aims to enable faster therapeutic assessment and more precise dosing for physicians in hospital settings.
Companies competing with Electra Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · Jul 2026Frequently asked questions
- What does Electra Therapeutics do?
- Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.
- Who are Electra Therapeutics's investors?
- Electra Therapeutics's investors include OrbiMed, RA Capital, Westlake Village BioPartners.
- How much funding has Electra Therapeutics raised?
- Electra Therapeutics has disclosed $134.2M raised across 1 round.
- Where is Electra Therapeutics headquartered?
- Electra Therapeutics is headquartered in South San Francisco, US.